BackBioNTech SE Overview
BioNTech SE - ADR

BioNTech SE Target Price

Where could BNTX trade next? Consensus target price: $130.

Get informed when a big investor buys or sells

+ Follow

Share Price

$98.52

Average Target Price

$128.4030.3% upside

5 analysts in the last 4 months

High: $142 | Low: $105

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-09-16Berenberg Bank$14042.1% upsideOpen
2026-09-08BMO CapitalEvan David Seigerman$1056.6% upsideOpen
2026-08-31Canaccord Genuity$13638% upsideOpen
2026-08-05Canaccord Genuity$14244.1% upsideOpen
2026-07-08Morgan Stanley$11920.8% upsideOpen
2026-05-27UBS$13537% upsideOpen
2026-05-21Bernstein$962.6% downsideOpen
2026-05-06Canaccord Genuity$15860.4% upsideOpen
2026-04-10Morgan StanleyTerence Flynn$12627.9% upsideOpen
2026-03-11BMO CapitalEvan David Seigerman$12829.9% upsideOpen
2026-03-10JefferiesAkash Tewari$13840.1% upsideOpen
2026-03-10Truist FinancialAsthika Goonewardene$15557.3% upsideOpen
2026-03-10Morgan Stanley$12829.9% upsideOpen
2026-02-02Leerink Partners$11314.7% upsideOpen
2026-01-16Goldman Sachs$14244.1% upsideOpen
2025-12-11Berenberg BankHarry Gillis$15557.3% upsideOpen
2025-12-11H.C. WainwrightRaghuram Selvaraju$14042.1% upsideOpen
2025-11-03Morgan Stanley$13436% upsideOpen
2025-10-10Morgan StanleyTerence Flynn$13133% upsideOpen
2025-08-05Wells FargoMohit Bansal$15052.3% upsideOpen
2025-07-10Morgan StanleyTerence Flynn$13335% upsideOpen
2025-06-02Leerink PartnersDaina Graybosch$11213.7% upsideOpen
2025-05-29Goldman SachsAsad Haider$11011.7% upsideOpen
2025-05-14H.C. WainwrightRobert Burns$13436% upsideOpen
2025-04-01H.C. Wainwright$14547.2% upsideOpen
2024-11-19Evercore ISICory Kasimov$12526.9% upsideOpen
2024-11-13Leerink PartnersDaina Graybosch$12122.8% upsideOpen
2024-11-08Goldman SachsChris Shibutani$13739.1% upsideOpen
2024-11-04BMO CapitalEtzer Darout$12627.9% upsideOpen
2024-09-23Morgan StanleyTerence Flynn$14547.2% upsideOpen
2024-09-17JefferiesAkash Tewari$15052.3% upsideOpen
2024-09-16Bank of America SecuritiesTazeen Ahmad$15052.3% upsideOpen
2024-09-13JefferiesAkash Tewari$962.6% downsideOpen
2024-08-06Deutsche BankEmmanuel Papadakis$953.6% downsideOpen
2024-08-05Morgan StanleyTerence Flynn$935.6% downsideOpen
2024-08-02HSBCYifeng Liu$1012.5% upsideOpen
2024-06-26H.C. WainwrightRaghuram Selvaraju$11314.7% upsideOpen
2024-05-13Evercore ISICory Kasimov$1001.5% upsideOpen
2024-05-07BMO CapitalEtzer Darout$12223.8% upsideOpen
2024-03-22HSBCYifeng Liu$908.6% downsideOpen
2024-03-21Canaccord GenuityWilliam Maughan$17173.6% upsideOpen
2024-03-21BMO CapitalEtzer Darout$12324.8% upsideOpen
2024-03-21Goldman SachsChris Shibutani$917.6% downsideOpen
2023-01-31Goldman Sachs$15658.3% upsideOpen
2022-12-02Leerink PartnersMani Foroohar$8117.8% downsideOpen
2022-05-17UBSAndrew Ang$16870.5% upsideOpen
2022-05-10Morgan StanleyMatthew Harrison$19597.9% upsideOpen
2022-04-16H.C. WainwrightRobert Burns$298202.5% upsideOpen
2022-04-10Canaccord GenuityArlinda Lee$300204.5% upsideOpen
2022-01-21UBSEliana Merle$17072.6% upsideOpen

BioNTech SE (BNTX) FAQ

BioNTech SE posts a target price of $130. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $130 for BNTX means covering analysts, on average, see the stock 30.3% upside of $98.52 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for BNTX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; BioNTech SE's other metric pages and overview cover the third.

Judging BioNTech SE against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $130 here, then scan peer and history charts to see if the gap is persistent.